HCA Healthcare Inc
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During January 2024 and January 2023, our Board of Directors authorized share repurchase programs for up to $6 billion and $3 billion, respectively, of our outstanding common stock. During the quarter ended March 31, 2024, we repurchased 3,893,746 shares of our common stock at an average price of $303.06 per share through market purchases pursuant to the January 2023 authorization (which was completed during the first quarter of 2024) and the January 2024 authorization. At March 31, 2024, we had $5.595 billion of repurchase authorization available under the January 2024 authorization.
The following table provides certain information with respect to our repurchases of common stock from January 1, 2024 through March 31, 2024 (dollars in billions, except per share amounts).
| Period | Total Numberof SharesPurchased | Average PricePaid per Share | Total Numberof SharesPurchased asPart ofPubliclyAnnouncedPlans orPrograms | ApproximateDollar Value ofShares ThatMay Yet BePurchasedUnder PubliclyAnnounced Plansor Programs |
|---|---|---|---|---|
| January 2024 | 1,426,082 | $280.50 | 1,426,082 | $6.375 |
| February 2024 | 1,227,827 | $309.50 | 1,227,827 | $5.995 |
| March 2024 | 1,239,837 | $322.63 | 1,239,837 | $5.595 |
| Total for first quarter 2024 | 3,893,746 | $303.06 | 3,893,746 |
On April 25, 2024, our Board of Directors declared a quarterly dividend of $0.66 per share on our common stock payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of our Board of Directors. Our ability to declare future dividends may also from time to time be limited by the terms of our debt agreements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.